SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001213900-24-053881
Filing Date
2024-06-18
Accepted
2024-06-18 17:17:29
Documents
79

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0205122-02.htm   iXBRL S-4/A 11619351
2 AMENDED AND RESTATED ANTIBODY DISCOVERY AND OPTION AGREEMENT (IL-17), DATED MARC ea020512202ex10-50_arcabio.htm EX-10.50 178865
3 AMENDED AND RESTATED ANTIBODY DISCOVERY AND OPTION AGREEMENT (IL-23), DATED MARC ea020512202ex10-51_arcabio.htm EX-10.51 201803
4 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF ARCA BIOPH ea020512202ex23-1_arcabio.htm EX-23.1 2908
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING ea020512202ex23-2_arcabio.htm EX-23.2 1459
6 GRAPHIC tarca_001.jpg GRAPHIC 61255
7 GRAPHIC toruka_logo.jpg GRAPHIC 97711
8 GRAPHIC timage_001.jpg GRAPHIC 596063
9 GRAPHIC timage_002.jpg GRAPHIC 920479
10 GRAPHIC timage_003.jpg GRAPHIC 237823
11 GRAPHIC timage_004.jpg GRAPHIC 319835
12 GRAPHIC timage_005.jpg GRAPHIC 121237
13 GRAPHIC timage_006.jpg GRAPHIC 315435
14 GRAPHIC timage_007.jpg GRAPHIC 321935
15 GRAPHIC tlucid_sig.jpg GRAPHIC 29511
16 GRAPHIC ex23-1_001.jpg GRAPHIC 2258
17 GRAPHIC ex23-1_002.jpg GRAPHIC 1836
  Complete submission text file 0001213900-24-053881.txt   26738782

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE abio-20240331.xsd EX-101.SCH 46307
19 XBRL CALCULATION FILE abio-20240331_cal.xml EX-101.CAL 31860
20 XBRL DEFINITION FILE abio-20240331_def.xml EX-101.DEF 252932
21 XBRL LABEL FILE abio-20240331_lab.xml EX-101.LAB 455915
22 XBRL PRESENTATION FILE abio-20240331_pre.xml EX-101.PRE 261648
83 EXTRACTED XBRL INSTANCE DOCUMENT ea0205122-02_htm.xml XML 1629075
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-279387 | Film No.: 241053031
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)